Crude Heads Higher as Trump Decertifies Iran Nuclear Deal and U.S. Rig Count Drops to Four-Month Low

Crude Heads Higher as Trump Decertifies Iran Nuclear Deal and U.S. Rig Count Drops to Four-Month Low

Crude kept its intraday gains after U.S. President Donald Trump opted not to certify Iran is complying with a nuclear deal signed in 2015, increasing geopolitical risk in the region. Oil prices headed higher this week off the back of stronger Chinese imports and as the U.S. oil rig count dropped to a four-month low. The number of oil rigs operating in the U.S. fell by five to 743, the […]

Read More ˃
Financial Shares Hold Slight Gains as Close Approaches

Financial Shares Hold Slight Gains as Close Approaches

Financial stocks were slightly higher this afternoon, with the NYSE Financial Sector Index (^NYK) climbing about 0.2% while financial companies in the S&P 500 Index (XLF) were adding about 0.1% in value today. In company news, Net Element (NETE) shares surged sharply higher on Friday, with the electronic payments processor today reporting strong growth in its North America Unified Payments division during the first half of its current fiscal year. […]

Read More ˃
Boeing Company Signs Seven New Customers for Boeing AnalytX

Boeing Company Signs Seven New Customers for Boeing AnalytX

The Boeing Company (BA) said Wednesday at the MRO Europe conference it has new agreements with seven customers for Boeing AnalytX, bringing the total amount of its analytics contracts signed this year to 223. Shares drifted slightly lower intraday. It said AnalytX brings together the work of more than 800 analytics experts across Boeing’s commercial, defense, and services businesses. The total value of the deal was not disclosed. Launched in […]

Read More ˃
Exelixis Earns $10 Mln Payment as Bristol-Myers Squibb Seeks Clinical Trial Authorization

Exelixis Earns $10 Mln Payment as Bristol-Myers Squibb Seeks Clinical Trial Authorization

Exelixis (EXEL) said Wednesday it received a $10 million milestone payment from Bristol-Myers Squibb (BMY). Shares climbed more than 2.5% intraday. The payment was made as part of the terms of a worldwide collaboration for compounds targeting retinoic acid-related orphan receptor (ROR), a family of nuclear hormone receptors implicated in inflammatory conditions, according to a statement. It was triggered by Bristol-Myers Squibb’s filing of a clinical trial authorization in Europe […]

Read More ˃
Bond Prices Tumble on ISM Jump

Bond Prices Tumble on ISM Jump

U.S. Treasury prices flipped lower following a surge in September services data, with the long bond leading lower while the two-year outperformed. Prices had been paring gains, grinding lower into the day’s second services sector report after an early push higher to Friday levels. Traders were eyeing the key technical 2.33% area on the 10-year. Ongoing chatter over who is being considered for the Federal Reserve chairmanship (including current head […]

Read More ˃